Nanomedicines Market Global Outlook, Research, Trends And Forecast To 2027
Nanomedicines Market |
Nanotechnology is a broad term
for nanoscale science, engineering, and technology that has enormous economic
and technological implications. One of the most prominent areas of
nanotechnology research is healthcare. Nanomedicine is defined as the use of
molecular tools and knowledge of the human body to diagnose, treat, and prevent
disease.
The high prevalence of chronic
diseases is expected to drive growth in the global nanomedicine market over the
forecast period. According to the American Cancer Society, there will be an
estimated 1,762,450 new cancer cases diagnosed in 2019 and 606,880 cancer
deaths in the United States. Furthermore, the establishment of NanoTherm
treatment centres is expected to aid in market growth. For example, in March
2020, MagForce AG and the Hufeland Klinikum GmbH announced the signing of a
joint cooperation agreement and the planned opening of a NanoTherm treatment
centre for brain tumours at the Mühlhausen site in Thuringia, Germany.
The lack of a well-organized
regulatory framework is expected to stymie the growth of the global
nanomedicine market. There are currently no specific testing requirements for
nanomedicine. However, the FDA, CDER, and other regulatory authorities around
the world have very strict safety testing requirements for any medical product.
Nanomedicine products are associated with environmental and toxicological
issues, making it mandatory for manufacturers to conduct toxicological studies
and follow environmental regulations while manufacturing. Toxicology,
pharmacology, ADME, carcinogenicity, immunotoxicity, and genotoxicity are
examples of current preclinical safety tests. Furthermore, low adoption of
nanomedicine in emerging economies is expected to limit market growth.
The Global Nanomedicine
Market Was Valued At US$ 177.1 Bn In 2019 And Is Forecast To Reach A
Value Of US$ 454.8 Bn By 2027 At A CAGR Of 12.5% Between 2020 And 2027.
The presence of unmet medical
needs in emerging economies is expected to provide lucrative growth
opportunities for players in the global nanomedicine market. Emerging and
high-growth markets such as China, Brazil, India, Eastern Europe, the Middle
East, and Latin America are expected to provide a plethora of opportunities for
the nanomedicine market in the future. This is because economic development in
these economies has provided patients with purchasing power induced by rising
disposable incomes. Improvements to healthcare infrastructure will enable the
use of sophisticated technologies while also meeting the population's high
unmet medical needs.
Furthermore, R&D in
nanomedicine is expected to contribute to market growth. For example, in August
2020, researchers at the Else Kröner-Fresenius-Stiftung Professorship,
Universitätsklinikum Erlangen, Germany, reported that superparamagnetic iron
oxide nanoparticles can function as an effective delivery platform to increase
local drug concentrations, potentially overcoming cell chemotherapy resistance.
For Press Release of Nanomedicines Market, visit- https://www.coherentmarketinsights.com/press-release/nanomedicines-market-3342
Comments
Post a Comment